5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
2L Options for EGFR+ NSCLC: How to Treat Osimertinib Resistance? What Is the Role of Anti-Angiogenic Therapy?
Login to view comments.
Click here to Login